ReviewBMJ (Clinical research ed.)2006
How NICE may be outflanked.
Review in BMJ (Clinical research ed.), 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Pooled it
- A hidden web of policy influence: The pharmaceutical industry's engagement with UK's All-Party Parliamentary Groups.PloS one · 2021Article
- Exposing drug industry funding of UK patient organisations.BMJ (Clinical research ed.) · 2019Article
- If You're a Rawlsian, How Come You're So Close to Utilitarianism and Intuitionism? A Critique of Daniels's Accountability for Reasonableness.Health care analysis : HCA : journal of health philosophy and policy · 2018Article
- Accounting for failure: risk-based regulation and the problems of ensuring healthcare quality in the NHS.Health, risk & society · 2016Article
- Academics and competing interests in H1N1 influenza media reporting.Journal of epidemiology and community health · 2014Article
- Coalition Priorité Cancer and the pharmaceutical industry in Quebec: conflicts of interest in the reimbursement of expensive cancer drugs?Healthcare policy = Politiques de sante · 2013Article
- Industry involvement and baseline assumptions of cost-effectiveness analyses: diagnostic accuracy of the Papanicolaou test.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2011Article
- Pedagogical promise and problems: teaching public health law.Public health · 2009Article
- The impact of cancer research: how publications influence UK cancer clinical guidelines.British journal of cancer · 2008Article
- Media influence on Herceptin subsidization in Australia: application of the rule of rescue?Journal of the Royal Society of Medicine · 2008Article
- Deconstructing media coverage of trastuzumab (Herceptin): an analysis of national newspaper coverage.Journal of the Royal Society of Medicine · 2008Article
- External influences and priority-setting for anti-cancer agents: a case study of media coverage in adjuvant trastuzumab for breast cancer.BMC cancer · 2007Review
- NICE work: level playing field requires transparency.BMJ (Clinical research ed.) · 2006Article
- NICE work: nice try.BMJ (Clinical research ed.) · 2006Article
Corrections and comments
- Commented on by
- Commented on by
- Comment on
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.